Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeholdingselskabet Lars Kofoed ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   1.8% 1.2% 1.5% 1.1% 2.0% 1.4% 10.0% 9.8%   Credit score (0-100)   74 84 77 83 68 76 25 25   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   2.4 127.1 23.1 177.7 0.7 25.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,402 1,990 1,877 2,027 2,489 2,218 0.0 0.0   EBITDA   78.3 546 432 580 967 536 0.0 0.0   EBIT   78.3 546 432 580 185 536 0.0 0.0   Pre-tax profit (PTP)   155.2 709.5 472.6 609.2 217.9 683.6 0.0 0.0   Net earnings   129.4 554.9 377.8 465.5 -5.0 531.0 0.0 0.0   Pre-tax profit without non-rec. items   155 709 473 609 218 684 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   3,603 3,958 3,836 4,101 3,596 3,627 3,227 3,227   Interest-bearing liabilities   243 140 209 94.1 71.7 0.0 0.0 0.0   Balance sheet total (assets)   4,021 4,229 4,456 4,596 4,084 3,928 3,227 3,227   Net Debt   243 140 209 94.1 71.7 -38.1 -3,227 -3,227     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,402 1,990 1,877 2,027 2,489 2,218 0.0 0.0   Gross profit growth   168.6% 41.9% -5.7% 8.0% 22.8% -10.9% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,021 4,229 4,456 4,596 4,084 3,928 3,227 3,227   Balance sheet change%   -0.9% 5.2% 5.4% 3.1% -11.1% -3.8% -17.8% 0.0%   Added value   78.3 545.7 432.4 579.9 185.2 535.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 -782 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   5.6% 27.4% 23.0% 28.6% 7.4% 24.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   4.0% 17.3% 11.1% 13.6% 5.4% 17.4% 0.0% 0.0%   ROI %   4.1% 18.0% 11.8% 14.9% 5.9% 19.1% 0.0% 0.0%   ROE %   3.5% 14.7% 9.7% 11.7% -0.1% 14.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   89.6% 93.6% 86.1% 89.2% 88.1% 92.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   310.5% 25.6% 48.4% 16.2% 7.4% -7.1% 0.0% 0.0%   Gearing %   6.7% 3.5% 5.5% 2.3% 2.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.6% 3.0% 4.4% 3.9% 19.9% 36.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   4.7 4.5 1.6 2.4 5.0 7.4 0.0 0.0   Current Ratio   4.7 4.5 1.6 2.4 5.0 7.4 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 0.0 38.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,558.3 956.6 392.2 670.9 1,902.8 1,925.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   78 546 432 580 185 536 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   78 546 432 580 967 536 0 0   EBIT / employee   78 546 432 580 185 536 0 0   Net earnings / employee   129 555 378 465 -5 531 0 0